PolyQ modulator (Boston Biomedical Research Inst)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePolyQ modulator (Boston Biomedical Research Inst)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome modulators
TargetsProteasome
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Biomedical Research Inst
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Biomedical Research Inst
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A